Report Cover

Global Vaccine Market Growth (Status and Outlook) 2021-2026


According to this latest study, the 2021 growth of Vaccine will have significant change from previous year. By the most conservative estimates of global Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
    Varicella Vaccine
    Influenza Vaccine
    Polio Vaccine
    Hepatitis A Vaccine
    Rabies Vaccine
    BCG Vaccine
    Hepatitis B
    Pertussis, Diphtheria, Tetanus
    Pneumococcal
    Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
    For Adult
    For Child

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
    AstraZeneca
    BioNTech
    Boehringer-Ingelheim
    CCBIO
    CSL
    CureVac
    Elanco
    GSK
    Hulan Bio
    Indian Immunologicals
    Merck
    Minhai Biotechnology
    Mitsubishi Tanabe Pharma
    Moderna Therapeutics
    Mylan
    Plumbline Life Sciences
    Sanofi
    Translate Bio
    Walvax Biotechnology
    Wuhan Institute of Biological Products
    Zoties
1 Scope of the Report
1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Vaccine Market Size 2016-2026
        2.1.2 Vaccine Market Size CAGR by Region 2020 VS 2021 VS 2026
    2.2 Vaccine Segment by Type
        2.2.1 Varicella Vaccine
        2.2.2 Varicella Vaccine
        2.2.3 Polio Vaccine
        2.2.4 Hepatitis A Vaccine
        2.2.5 Rabies Vaccine
        2.2.6 BCG Vaccine
        2.2.7 Hepatitis B
        2.2.8 Pertussis, Diphtheria, Tetanus
        2.2.9 Pneumococcal
        2.2.10 Others
    2.3 Vaccine Market Size by Type
        2.3.1 Global Vaccine Market Size CAGR by Type
        2.3.2 Global Vaccine Market Size Market Share by Type (2016-2021)
    2.4 Vaccine Segment by Application
        2.4.1 For Adult
        2.4.2 For Child
    2.5 Vaccine Market Size by Application
        2.5.1 Global Vaccine Market Size CAGR by Application
        2.5.2 Global Vaccine Market Size Market Share by Application (2016-2021)

3 Vaccine Market Size by Players
    3.1 Vaccine Market Size Market Share by Players
        3.1.1 Global Vaccine Revenue by Players (2019-2021E)
        3.1.2 Global Vaccine Revenue Market Share by Players (2019-2021E)
    3.2 Global Vaccine Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Vaccine by Regions
    4.1 Vaccine Market Size by Regions (2016-2021)
    4.2 Americas Vaccine Market Size Growth (2016-2021)
    4.3 APAC Vaccine Market Size Growth (2016-2021)
    4.4 Europe Vaccine Market Size Growth (2016-2021)
    4.5 Middle East & Africa Vaccine Market Size Growth (2016-2021)

5 Americas
    5.1 Americas Vaccine Market Size by Country (2016-2021)
    5.2 Americas Vaccine Market Size by Type (2016-2021)
    5.3 Americas Vaccine Market Size by Application (2016-2021)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Vaccine Market Size by Region (2016-2021)
    6.2 APAC Vaccine Market Size by Type (2016-2021)
    6.3 APAC Vaccine Market Size by Application (2016-2021)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Vaccine by Country (2016-2021)
    7.2 Europe Vaccine Market Size by Type (2016-2021)
    7.3 Europe Vaccine Market Size by Application (2016-2021)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Vaccine by Region (2016-2021)
    8.2 Middle East & Africa Vaccine Market Size by Type (2016-2021)
    8.3 Middle East & Africa Vaccine Market Size by Application (2016-2021)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
        9.1.1 Growing Demand from Key Regions
        9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

10 Global Vaccine Market Forecast
    10.1 Global Vaccine Forecast by Regions (2021-2026)
        10.1.1 Global Vaccine Forecast by Regions (2021-2026)
        10.1.2 Americas Vaccine Forecast
        10.1.3 APAC Vaccine Forecast
        10.1.4 Europe Vaccine Forecast
        10.1.5 Middle East & Africa Vaccine Forecast
    10.2 Americas Vaccine Forecast by Countries (2021-2026)
        10.2.1 United States Vaccine Market Forecast
        10.2.2 Canada Vaccine Market Forecast
        10.2.3 Mexico Vaccine Market Forecast
        10.2.4 Brazil Vaccine Market Forecast
    10.3 APAC Vaccine Forecast by Region (2021-2026)
        10.3.1 China Vaccine Market Forecast
        10.3.2 Japan Vaccine Market Forecast
        10.3.3 Korea Vaccine Market Forecast
        10.3.4 Southeast Asia Vaccine Market Forecast
        10.3.5 India Vaccine Market Forecast
        10.3.6 Australia Vaccine Market Forecast
    10.4 Europe Vaccine Forecast by Country (2021-2026)
        10.4.1 Germany Vaccine Market Forecast
        10.4.2 France Vaccine Market Forecast
        10.4.3 UK Vaccine Market Forecast
        10.4.4 Italy Vaccine Market Forecast
        10.4.5 Russia Vaccine Market Forecast
    10.5 Middle East & Africa Vaccine Forecast by Region (2021-2026)
        10.5.1 Egypt Vaccine Market Forecast
        10.5.2 South Africa Vaccine Market Forecast
        10.5.3 Israel Vaccine Market Forecast
        10.5.4 Turkey Vaccine Market Forecast
        10.5.5 GCC Countries Vaccine Market Forecast
    10.6 Global Vaccine Forecast by Type (2021-2026)
    10.8 Global Vaccine Forecast by Application (2021-2026)

11 Key Players Analysis
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Information
        11.1.2 AstraZeneca Vaccine Product Offered
        11.1.3 AstraZeneca Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.1.4 AstraZeneca Main Business Overview
        11.1.5 AstraZeneca Latest Developments
    11.2 BioNTech
        11.2.1 BioNTech Company Information
        11.2.2 BioNTech Vaccine Product Offered
        11.2.3 BioNTech Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.2.4 BioNTech Main Business Overview
        11.2.5 BioNTech Latest Developments
    11.3 Boehringer-Ingelheim
        11.3.1 Boehringer-Ingelheim Company Information
        11.3.2 Boehringer-Ingelheim Vaccine Product Offered
        11.3.3 Boehringer-Ingelheim Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.3.4 Boehringer-Ingelheim Main Business Overview
        11.3.5 Boehringer-Ingelheim Latest Developments
    11.4 CCBIO
        11.4.1 CCBIO Company Information
        11.4.2 CCBIO Vaccine Product Offered
        11.4.3 CCBIO Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.4.4 CCBIO Main Business Overview
        11.4.5 CCBIO Latest Developments
    11.5 CSL
        11.5.1 CSL Company Information
        11.5.2 CSL Vaccine Product Offered
        11.5.3 CSL Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.5.4 CSL Main Business Overview
        11.5.5 CSL Latest Developments
    11.6 CureVac
        11.6.1 CureVac Company Information
        11.6.2 CureVac Vaccine Product Offered
        11.6.3 CureVac Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.6.4 CureVac Main Business Overview
        11.6.5 CureVac Latest Developments
    11.7 Elanco
        11.7.1 Elanco Company Information
        11.7.2 Elanco Vaccine Product Offered
        11.7.3 Elanco Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.7.4 Elanco Main Business Overview
        11.7.5 Elanco Latest Developments
    11.8 GSK
        11.8.1 GSK Company Information
        11.8.2 GSK Vaccine Product Offered
        11.8.3 GSK Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.8.4 GSK Main Business Overview
        11.8.5 GSK Latest Developments
    11.9 Hulan Bio
        11.9.1 Hulan Bio Company Information
        11.9.2 Hulan Bio Vaccine Product Offered
        11.9.3 Hulan Bio Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.9.4 Hulan Bio Main Business Overview
        11.9.5 Hulan Bio Latest Developments
    11.10 Indian Immunologicals
        11.10.1 Indian Immunologicals Company Information
        11.10.2 Indian Immunologicals Vaccine Product Offered
        11.10.3 Indian Immunologicals Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.10.4 Indian Immunologicals Main Business Overview
        11.10.5 Indian Immunologicals Latest Developments
    11. Merck
        11.11.1 Merck Company Information
        11.11.2 Merck Vaccine Product Offered
        11.11.3 Merck Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.11.4 Merck Main Business Overview
        11.11.5 Merck Latest Developments
    11.12 Minhai Biotechnology
        11.12.1 Minhai Biotechnology Company Information
        11.12.2 Minhai Biotechnology Vaccine Product Offered
        11.12.3 Minhai Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.12.4 Minhai Biotechnology Main Business Overview
        11.12.5 Minhai Biotechnology Latest Developments
    11.13 Mitsubishi Tanabe Pharma
        11.13.1 Mitsubishi Tanabe Pharma Company Information
        11.13.2 Mitsubishi Tanabe Pharma Vaccine Product Offered
        11.13.3 Mitsubishi Tanabe Pharma Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.13.4 Mitsubishi Tanabe Pharma Main Business Overview
        11.13.5 Mitsubishi Tanabe Pharma Latest Developments
    11.14 Moderna Therapeutics
        11.14.1 Moderna Therapeutics Company Information
        11.14.2 Moderna Therapeutics Vaccine Product Offered
        11.14.3 Moderna Therapeutics Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.14.4 Moderna Therapeutics Main Business Overview
        11.14.5 Moderna Therapeutics Latest Developments
    11.15 Mylan
        11.15.1 Mylan Company Information
        11.15.2 Mylan Vaccine Product Offered
        11.15.3 Mylan Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.15.4 Mylan Main Business Overview
        11.15.5 Mylan Latest Developments
    11.16 Plumbline Life Sciences
        11.16.1 Plumbline Life Sciences Company Information
        11.16.2 Plumbline Life Sciences Vaccine Product Offered
        11.16.3 Plumbline Life Sciences Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.16.4 Plumbline Life Sciences Main Business Overview
        11.16.5 Plumbline Life Sciences Latest Developments
    11.17 Sanofi
        11.17.1 Sanofi Company Information
        11.17.2 Sanofi Vaccine Product Offered
        11.17.3 Sanofi Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.17.4 Sanofi Main Business Overview
        11.17.5 Sanofi Latest Developments
    11.18 Translate Bio
        11.18.1 Translate Bio Company Information
        11.18.2 Translate Bio Vaccine Product Offered
        11.18.3 Translate Bio Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.18.4 Translate Bio Main Business Overview
        11.18.5 Translate Bio Latest Developments
    11.19 Walvax Biotechnology
        11.19.1 Walvax Biotechnology Company Information
        11.19.2 Walvax Biotechnology Vaccine Product Offered
        11.19.3 Walvax Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.19.4 Walvax Biotechnology Main Business Overview
        11.19.5 Walvax Biotechnology Latest Developments
    11.20 Wuhan Institute of Biological Products
        11.20.1 Wuhan Institute of Biological Products Company Information
        11.20.2 Wuhan Institute of Biological Products Vaccine Product Offered
        11.20.3 Wuhan Institute of Biological Products Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.20.4 Wuhan Institute of Biological Products Main Business Overview
        11.20.5 Wuhan Institute of Biological Products Latest Developments
    11.21 Zoties
        11.21.1 Zoties Company Information
        11.21.2 Zoties Vaccine Product Offered
        11.21.3 Zoties Vaccine Revenue, Gross Margin and Market Share (2019-2021)
        11.21.4 Zoties Main Business Overview
        11.21.5 Zoties Latest Developments

12 Research Findings and Conclusion

List of Tables Table 1. Vaccine Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Varicella Vaccine Table 3. Major Players of Influenza Vaccine Table 4. Major Players of Polio Vaccine Table 5. Major Players of Hepatitis A Vaccine Table 6. Major Players of Rabies Vaccine Table 7. Major Players of BCG Vaccine Table 8. Major Players of Hepatitis B Table 9. Major Players of Pertussis, Diphtheria, Tetanus Table 10. Major Players of Pneumococcal Table 11. Major Players of Others Table 12. Vaccine Market Size CAGR by Type (2020-2026) & ($ Millions) Table 13. Global Vaccine Market Size by Type (2016-2021) & ($ Millions) Table 14. Global Vaccine Market Size Market Share by Type (2016-2021) Table 15. Vaccine Market Size CAGR by Application (2016-2021) & ($ Millions) Table 16. Global Vaccine Market Size by Application (2016-2021) & ($ Millions) Table 17. Global Vaccine Market Size Market Share by Application (2016-2021) Table 18. Global Vaccine Revenue by Players (2019-2021E) & ($ Millions) Table 19. Global Vaccine Revenue Market Share by Players (2019-2021E) Table 20. Vaccine Key Players Head office and Products Offered Table 21. Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Vaccine Market Size by Regions 2016-2021 & ($ Millions) Table 25. Global Vaccine Market Size Market Share by Regions 2016-2021 Table 26. Americas Vaccine Market Size by Country (2016-2021) & ($ Millions) Table 27. Americas Vaccine Market Size Market Share by Country (2016-2021) Table 28. Americas Vaccine Market Size by Type (2016-2021) & ($ Millions) Table 29. Americas Vaccine Market Size Market Share by Type (2016-2021) Table 30. Americas Vaccine Market Size by Application (2016-2021) & ($ Millions) Table 31. Americas Vaccine Market Size Market Share by Application (2016-2021) Table 32. APAC Vaccine Market Size by Region (2016-2021) & ($ Millions) Table 33. APAC Vaccine Market Size Market Share by Region (2016-2021) Table 34. APAC Vaccine Market Size by Type (2016-2021) & ($ Millions) Table 35. APAC Vaccine Market Size Market Share by Type (2016-2021) Table 36. APAC Vaccine Market Size by Application (2016-2021) & ($ Millions) Table 37. APAC Vaccine Market Size Market Share by Application (2016-2021) Table 38. Europe Vaccine Market Size by Country (2016-2021) & ($ Millions) Table 39. Europe Vaccine Market Size Market Share by Country (2016-2021) Table 40. Europe Vaccine Market Size by Type (2016-2021) & ($ Millions) Table 41. Europe Vaccine Market Size Market Share by Type (2016-2021) Table 42. Europe Vaccine Market Size by Application (2016-2021) & ($ Millions) Table 43. Europe Vaccine Market Size Market Share by Application (2016-2021) Table 44. Middle East & Africa Vaccine Market Size by Region (2016-2021) & ($ Millions) Table 45. Middle East & Africa Vaccine Market Size Market Share by Region (2016-2021) Table 46. Middle East & Africa Vaccine Market Size by Type (2016-2021) & ($ Millions) Table 47. Middle East & Africa Vaccine Market Size Market Share by Type (2016-2021) Table 48. Middle East & Africa Vaccine Market Size by Application (2016-2021) & ($ Millions) Table 49. Middle East & Africa Vaccine Market Size Market Share by Application (2016-2021) Table 50. Key and Potential Regions of Vaccine Table 51. Key Application and Potential Industries of Vaccine Table 52. Key Challenges of Vaccine Table 53. Key Trends of Vaccine Table 54. Global Vaccine Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 55. Global Vaccine Market Size Market Share Forecast by Regions (2021-2026) Table 56. Global Vaccine Market Size Forecast by Type (2021-2026) & ($ Millions) Table 57. Global Vaccine Market Size Market Share Forecast by Type (2021-2026) Table 58. Global Vaccine Market Size Forecast by Application (2021-2026) & ($ Millions) Table 59. Global Vaccine Market Size Market Share Forecast by Application (2021-2026) Table 60. AstraZeneca Details, Company Type, Vaccine Area Served and Its Competitors Table 61. AstraZeneca Vaccine Product Offered Table 62. AstraZeneca Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 63. AstraZeneca Main Business Table 64. AstraZeneca Latest Developments Table 65. BioNTech Details, Company Type, Vaccine Area Served and Its Competitors Table 66. BioNTech Vaccine Product Offered Table 67. BioNTech Main Business Table 68. BioNTech Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 69. BioNTech Latest Developments Table 70. Boehringer-Ingelheim Details, Company Type, Vaccine Area Served and Its Competitors Table 71. Boehringer-Ingelheim Vaccine Product Offered Table 72. Boehringer-Ingelheim Main Business Table 73. Boehringer-Ingelheim Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 74. Boehringer-Ingelheim Latest Developments Table 75. CCBIO Details, Company Type, Vaccine Area Served and Its Competitors Table 76. CCBIO Vaccine Product Offered Table 77. CCBIO Main Business Table 78. CCBIO Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 79. CCBIO Latest Developments Table 80. CSL Details, Company Type, Vaccine Area Served and Its Competitors Table 81. CSL Vaccine Product Offered Table 82. CSL Main Business Table 83. CSL Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 84. CSL Latest Developments Table 85. CureVac Details, Company Type, Vaccine Area Served and Its Competitors Table 86. CureVac Vaccine Product Offered Table 87. CureVac Main Business Table 88. CureVac Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 89. CureVac Latest Developments Table 90. Elanco Details, Company Type, Vaccine Area Served and Its Competitors Table 91. Elanco Vaccine Product Offered Table 92. Elanco Main Business Table 93. Elanco Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 94. Elanco Latest Developments Table 95. GSK Details, Company Type, Vaccine Area Served and Its Competitors Table 96. GSK Vaccine Product Offered Table 97. GSK Main Business Table 98. GSK Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 99. GSK Latest Developments Table 100. Hulan Bio Details, Company Type, Vaccine Area Served and Its Competitors Table 101. Hulan Bio Vaccine Product Offered Table 102. Hulan Bio Main Business Table 103. Hulan Bio Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 104. Hulan Bio Latest Developments Table 105. Indian Immunologicals Details, Company Type, Vaccine Area Served and Its Competitors Table 106. Indian Immunologicals Vaccine Product Offered Table 107. Indian Immunologicals Main Business Table 108. Indian Immunologicals Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 109. Indian Immunologicals Latest Developments Table 110. Merck Details, Company Type, Vaccine Area Served and Its Competitors Table 111. Merck Vaccine Product Offered Table 112. Merck Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 113. Merck Main Business Table 114. Merck Latest Developments Table 115. Minhai Biotechnology Details, Company Type, Vaccine Area Served and Its Competitors Table 116. Minhai Biotechnology Vaccine Product Offered Table 117. Minhai Biotechnology Main Business Table 118. Minhai Biotechnology Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 119. Minhai Biotechnology Latest Developments Table 120. Mitsubishi Tanabe Pharma Details, Company Type, Vaccine Area Served and Its Competitors Table 121. Mitsubishi Tanabe Pharma Vaccine Product Offered Table 122. Mitsubishi Tanabe Pharma Main Business Table 123. Mitsubishi Tanabe Pharma Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 124. Mitsubishi Tanabe Pharma Latest Developments Table 125. Moderna Therapeutics Details, Company Type, Vaccine Area Served and Its Competitors Table 126. Moderna Therapeutics Vaccine Product Offered Table 127. Moderna Therapeutics Main Business Table 128. Moderna Therapeutics Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 129. Moderna Therapeutics Latest Developments Table 130. Mylan Details, Company Type, Vaccine Area Served and Its Competitors Table 131. Mylan Vaccine Product Offered Table 132. Mylan Main Business Table 133. Mylan Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 134. Mylan Latest Developments Table 135. Plumbline Life Sciences Details, Company Type, Vaccine Area Served and Its Competitors Table 136. Plumbline Life Sciences Vaccine Product Offered Table 137. Plumbline Life Sciences Main Business Table 138. Plumbline Life Sciences Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 139. Plumbline Life Sciences Latest Developments Table 140. Sanofi Details, Company Type, Vaccine Area Served and Its Competitors Table 141. Sanofi Vaccine Product Offered Table 142. Sanofi Main Business Table 143. Sanofi Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 144. Sanofi Latest Developments Table 145. Translate Bio Details, Company Type, Vaccine Area Served and Its Competitors Table 146. Translate Bio Vaccine Product Offered Table 147. Translate Bio Main Business Table 148. Translate Bio Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 149. Translate Bio Latest Developments Table 150. Walvax Biotechnology Details, Company Type, Vaccine Area Served and Its Competitors Table 151. Walvax Biotechnology Vaccine Product Offered Table 152. Walvax Biotechnology Main Business Table 153. Walvax Biotechnology Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 154. Walvax Biotechnology Latest Developments Table 155. Wuhan Institute of Biological Products Details, Company Type, Vaccine Area Served and Its Competitors Table 156. Wuhan Institute of Biological Products Vaccine Product Offered Table 157. Wuhan Institute of Biological Products Main Business Table 158. Wuhan Institute of Biological Products Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 159. Wuhan Institute of Biological Products Latest Developments Table 160. Zoties Details, Company Type, Vaccine Area Served and Its Competitors Table 161. Zoties Vaccine Product Offered Table 162. Zoties Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 163. Zoties Main Business Table 164. Zoties Latest Developments List of Figures Figure 1. Vaccine Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Vaccine Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Vaccine Market Size Market Share by Type in 2020 Figure 7. Vaccine in For Adult Figure 8. Global Vaccine Market: For Adult (2016-2021) & ($ Millions) Figure 9. Vaccine in For Child Figure 10. Global Vaccine Market: For Child (2016-2021) & ($ Millions) Figure 11. Global Vaccine Market Size Market Share by Application in 2020 Figure 12. Global Vaccine Revenue Market Share by Player in 2020 Figure 13. Global Vaccine Market Size Market Share by Regions (2016-2021) Figure 14. Americas Vaccine Market Size 2016-2021 ($ Millions) Figure 15. APAC Vaccine Market Size 2016-2021 ($ Millions) Figure 16. Europe Vaccine Market Size 2016-2021 ($ Millions) Figure 17. Middle East & Africa Vaccine Market Size 2016-2021 ($ Millions) Figure 18. Americas Vaccine Market Size Market Share by Country in 2020 Figure 19. Americas Vaccine Market Size Market Share by Type in 2020 Figure 20. Americas Vaccine Market Size Market Share by Application in 2020 Figure 21. United States Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 22. Canada Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 23. Mexico Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 24. APAC Vaccine Market Size Market Share by Regions in 2020 Figure 25. APAC Vaccine Market Size Market Share by Type in 2020 Figure 26. APAC Vaccine Market Size Market Share by Application in 2020 Figure 27. China Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 28. Japan Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 29. Korea Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 30. Southeast Asia Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 31. India Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 32. Australia Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 33. Europe Vaccine Market Size Market Share by Country in 2020 Figure 34. Europe Vaccine Market Size Market Share by Type in 2020 Figure 35. Europe Vaccine Market Size Market Share by Application in 2020 Figure 36. Germany Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 37. France Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 38. UK Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 39. Italy Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 40. Russia Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 41. Middle East & Africa Vaccine Market Size Market Share by Region in 2020 Figure 42. Middle East & Africa Vaccine Market Size Market Share by Type in 2020 Figure 43. Middle East & Africa Vaccine Market Size Market Share by Application in 2020 Figure 44. Egypt Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 45. South Africa Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 46. Israel Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 47. Turkey Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 48. GCC Country Vaccine Market Size Growth 2016-2021 ($ Millions) Figure 49. Americas Vaccine Market Size 2021-2026 ($ Millions) Figure 50. APAC Vaccine Market Size 2021-2026 ($ Millions) Figure 51. Europe Vaccine Market Size 2021-2026 ($ Millions) Figure 52. Middle East & Africa Vaccine Market Size 2021-2026 ($ Millions) Figure 53. United States Vaccine Market Size 2021-2026 ($ Millions) Figure 54. Canada Vaccine Market Size 2021-2026 ($ Millions) Figure 55. Mexico Vaccine Market Size 2021-2026 ($ Millions) Figure 56. Brazil Vaccine Market Size 2021-2026 ($ Millions) Figure 57. China Vaccine Market Size 2021-2026 ($ Millions) Figure 58. Japan Vaccine Market Size 2021-2026 ($ Millions) Figure 59. Korea Vaccine Market Size 2021-2026 ($ Millions) Figure 60. Southeast Asia Vaccine Market Size 2021-2026 ($ Millions) Figure 61. India Vaccine Market Size 2021-2026 ($ Millions) Figure 62. Australia Vaccine Market Size 2021-2026 ($ Millions) Figure 63. Germany Vaccine Market Size 2021-2026 ($ Millions) Figure 64. France Vaccine Market Size 2021-2026 ($ Millions) Figure 65. UK Vaccine Market Size 2021-2026 ($ Millions) Figure 66. Italy Vaccine Market Size 2021-2026 ($ Millions) Figure 67. Russia Vaccine Market Size 2021-2026 ($ Millions) Figure 68. Spain Vaccine Market Size 2021-2026 ($ Millions) Figure 69. Egypt Vaccine Market Size 2021-2026 ($ Millions) Figure 70. South Africa Vaccine Market Size 2021-2026 ($ Millions) Figure 71. Israel Vaccine Market Size 2021-2026 ($ Millions) Figure 72. Turkey Vaccine Market Size 2021-2026 ($ Millions) Figure 73. GCC Country Vaccine Market Size 2021-2026 ($ Millions)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: LP Information Inc
Chat with us